<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Hum Mol Genet</journal-id>
<journal-id journal-id-type="iso-abbrev">Hum. Mol. Genet</journal-id>
<journal-id journal-id-type="publisher-id">hmg</journal-id>
<journal-id journal-id-type="hwp">hmg</journal-id>
<journal-title-group>
<journal-title>Human Molecular Genetics</journal-title>
</journal-title-group>
<issn pub-type="ppub">0964-6906</issn>
<issn pub-type="epub">1460-2083</issn>
<publisher>
<publisher-name>Oxford University Press</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">27516385</article-id>
<article-id pub-id-type="pmc">5291199</article-id>
<article-id pub-id-type="doi">10.1093/hmg/ddw265</article-id>
<article-id pub-id-type="publisher-id">ddw265</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Articles</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>The human-specific <italic>CASP4</italic> gene product contributes to Alzheimer-related synaptic and behavioural deficits</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Kajiwara</surname>
<given-names>Yuji</given-names>
</name>
<xref ref-type="aff" rid="ddw265-aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>McKenzie</surname>
<given-names>Andrew</given-names>
</name>
<xref ref-type="aff" rid="ddw265-aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="ddw265-aff3">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Dorr</surname>
<given-names>Nate</given-names>
</name>
<xref ref-type="aff" rid="ddw265-aff4">
<sup>4</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gama Sosa</surname>
<given-names>Miguel A.</given-names>
</name>
<xref ref-type="aff" rid="ddw265-aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="ddw265-aff4">
<sup>4</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Elder</surname>
<given-names>Gregory</given-names>
</name>
<xref ref-type="aff" rid="ddw265-aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="ddw265-aff5">
<sup>5</sup>
</xref>
<xref ref-type="aff" rid="ddw265-aff6">
<sup>6</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Schmeidler</surname>
<given-names>James</given-names>
</name>
<xref ref-type="aff" rid="ddw265-aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Dickstein</surname>
<given-names>Dara L.</given-names>
</name>
<xref ref-type="aff" rid="ddw265-aff7">
<sup>7</sup>
</xref>
<xref ref-type="aff" rid="ddw265-aff8">
<sup>8</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bozdagi</surname>
<given-names>Ozlem</given-names>
</name>
<xref ref-type="aff" rid="ddw265-aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhang</surname>
<given-names>Bin</given-names>
</name>
<xref ref-type="aff" rid="ddw265-aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="ddw265-aff3">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Buxbaum</surname>
<given-names>Joseph D.</given-names>
</name>
<xref ref-type="aff" rid="ddw265-aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="ddw265-aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="ddw265-aff7">
<sup>7</sup>
</xref>
<xref ref-type="aff" rid="ddw265-aff8">
<sup>8</sup>
</xref>
<xref ref-type="corresp" rid="ddw265-cor1">*</xref>
</contrib>
<aff id="ddw265-aff1"><label>1</label>Department of Psychiatry</aff>
<aff id="ddw265-aff2"><label>2</label>Department of Genetics and Genomic Sciences</aff>
<aff id="ddw265-aff3"><label>3</label>Icahn Institute of Genomics and Multiscale Biology, Icahn School of Medicine at Mount Sinai, NY, USA</aff>
<aff id="ddw265-aff4"><label>4</label>General Medical Research Service</aff>
<aff id="ddw265-aff5"><label>5</label>Neurology Service, James J. Peters Department of Veterans Affairs Medical Center, Bronx, NY, USA</aff>
<aff id="ddw265-aff6"><label>6</label>Department of Neurology</aff>
<aff id="ddw265-aff7"><label>7</label>Department of Neuroscience</aff>
<aff id="ddw265-aff8"><label>8</label>Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA</aff>
</contrib-group>
<author-notes>
<corresp id="ddw265-cor1"><label>*</label>To whom correspondence should be addressed at: Joseph D Buxbaum, Department of Psychiatry, Icahn School of Medicine, Mount Sinai, One Gustave L. Levy Place, Box 1668, New York, NY 10029-6574, USA. Tel: +1-212-241-0200; Fax: +212-828-4221; Email: <email>Joseph.Buxbaum@mssm.edu</email></corresp>
</author-notes>
<pub-date pub-type="ppub">
<day>01</day>
<month>10</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="epub">
<day>11</day>
<month>8</month>
<year>2016</year>
</pub-date>
<volume>25</volume>
<issue>19</issue>
<fpage>4315</fpage>
<lpage>4327</lpage>
<history>
<date date-type="received">
<day>04</day>
<month>3</month>
<year>2016</year>
</date>
<date date-type="rev-recd">
<day>9</day>
<month>6</month>
<year>2016</year>
</date>
<date date-type="accepted">
<day>28</day>
<month>7</month>
<year>2016</year>
</date>
</history>
<permissions>
<copyright-statement>© The Author 2016. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com</copyright-statement>
<copyright-year>2016</copyright-year>
</permissions>
<abstract>
<p>Recent studies have indicated that innate immune signalling molecules are involved in late-onset Alzheimer's disease (LOAD) risk. Amyloid beta (Aβ) accumulates in AD brain, and has been proposed to act as a trigger of innate immune responses. Caspase-4 is an important part of the innate immune response. We recently characterized transgenic mice carrying human <italic>CASP4</italic>, and observed that the mice manifested profound innate immune responses to lipopolysaccharide (LPS). Since these inflammatory processes are important in the aetiology of AD, we have now analysed the correlation of expression of caspase-4 in human brain with AD risk genes, and studied caspase-4 effects on AD-related phenotypes in APPswe/PS1deltaE9 (APP/PS1) mice. We observed that the expression of caspase-4 was strongly correlated with AD risk genes including <italic>TYROBP</italic>, <italic>TREM2</italic>, <italic>CR1</italic>, <italic>PSEN1</italic>, <italic>MS4A4A</italic> and <italic>MS4A6A</italic> in LOAD brains. Caspase-4 expression was upregulated in CASP4/APP/PS1 mice in a region-specific manner, including hippocampus and prefrontal cortex. In APP/PS1 mice, caspase-4 expression led to impairments in the reversal phase of a Barnes maze task and in hippocampal synaptic plasticity, without affecting soluble or aggregated Aβ levels. Caspase-4 was expressed predominantly in microglial cells, and in the presence of CASP4, more microglia were clustered around amyloid plaques. Furthermore, our data indicated that caspase-4 modulates microglial cells in a manner that increases proinflammatory processes. We propose that microglial caspase-4 expression contributes to the cognitive impairments in AD, and that further study of caspase-4 will enhance our understanding of AD pathogenesis and may lead to novel therapeutic targets in AD.</p>
</abstract>
<counts>
<page-count count="13"></page-count>
</counts>
</article-meta>
</front>
</article>
</pmc-articleset>